Work

From bench to bedside – preclinical and early clinical development of the anticancer agent indazolium trans-[tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019 or FFC14A)

Year: 2006

Type: review

Source: Journal of Inorganic Biochemistry

DOI: 10.1016/j.jinorgbio.2006.02.013

Authors: Christian G. Hartinger, Stefanie Zorbas-Seifried, Michael A. Jakupec, Bernd Kynast, Haralabos Zorbas, Bernhard K. Keppler

Institutions: University of Vienna, Max Planck Society, Max Planck Institute of Biochemistry

Language: English

Topic: Metal complexes synthesis and properties

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Austrian Science Fund, Rat für Forschung und Technologieentwicklung, Freistaat Sachsen

OpenAlex ID: W2020462998

FWCI: 6.158

Cites: 63

Cited by: 986

Related to: 8